Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
GYRE
Gyre Therapeutics CEO expects pivotal phase 3 trial results in 2025
| 2024-11-13 |
PHARMACEUTICAL
Gyre Therapeutics Reports Q2 Revenue Drop
| 2024-08-13 |
UNITED STATES
